Loading...

Kirr Marbach Partners Value Fund

KMVAX•NASDAQ
Financial Services
Asset Management
$35.77
$0.66(1.88%)
U.S. Market opens in 2h 16m

Kirr Marbach Partners Value Fund (KMVAX) Stock Overview

Explore Kirr Marbach Partners Value Fund’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap108.7M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$34.98
3 Months$36.39
1 Year Target$42.00

KMVAX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kirr Marbach Partners Value Fund (KMVAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $42.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 108.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.34%
5-Day Change
-1.93%
1-Month Change
-8.55%
3-Month Change
-1.25%
6-Month Change
-10.51%
Year-to-Date (YTD) Change
-2.23%
1-Year Change
14.10%
3-Year Change
39.45%
5-Year Change
35.47%
All-Time (Max) Change
246.40%

Contact Information

NaN
8123769444
621 Washington Street, Columbus, IN, 47202

Company Facts

IPO DateDec 31, 1998
CountryUS
Actively Trading

Frequently Asked Questions